Jun 20, 2021 by Patrick Bafuma3 More Reasons Biogen's Alzheimer's Drug Will Underperform Wall Street ExpectationsBeyond its lofty price tag, there are other impediments to big sales of aducanamab that the market largely ignored this week.
Jun 20, 2021 by Patrick BafumaDid This Company Just Win Big Because of Biogen?Alzheimer's disease patients who take Aduhelm will need a lot of diagnostic scans, too. Imaging leader RadNet stands to benefit.
May 30, 2021 by Patrick BafumaThis Recent Healthcare IPO Posted Solid Earnings, but Wall Street Wasn't ListeningWith strong revenue growth and a new product about to launch, hearing aid upstart Eargo could be worth investors' attention.
May 27, 2021 by Patrick BafumaWall Street Flies Away From Butterfly Networks After Its Second Earnings ReportDespite on-target revenue growth, investors were not convinced about the medical device company's growth plans.
May 22, 2021 by Patrick BafumaWith Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble?Guardant Health released earnings earlier this month, disappointing investors with its sluggish revenue growth and increasing expenses.
May 20, 2021 by Patrick BafumaDown More Than 20%, Is This Cathie Wood Biotech A Buy?10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
May 15, 2021 by Patrick BafumaExact Sciences' First-Quarter Results Show Its Strength Under PressureDespite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?
May 7, 2021 by Patrick BafumaThis Under-the-Radar Healthcare Company Quietly Surged During the PandemicCareDx just posted 76% year-over-year revenue growth for the first quarter and raised its 2021 guidance.
May 4, 2021 by Patrick BafumaAbiomed to Shareholders: Patience Please, Growth Is On The Way.Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming.
Apr 29, 2021 by Patrick BafumaAt a Recent Cancer Research Conference, Instil Bio Stole the ShowThe clinical-stage cell therapy company reported impressive response rates for its candidate treatment against metastatic melanoma.
Apr 24, 2021 by Patrick Bafuma3 Healthcare Stocks About to be Bolstered by Biden's American Rescue PlanThe government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
Apr 22, 2021 by Patrick Bafuma1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into RichesTransMedics is looking to disrupt an entire industry and help thousands of transplant patients in the U.S. in the process.
Apr 19, 2021 by Patrick BafumaWhat Does J&J's Pause Mean for Investors?How much will the healthcare giant suffer, and what does this mean for worldwide vaccination efforts?
Apr 17, 2021 by Patrick Bafuma3 Biden Healthcare Stocks to WatchThe administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.
Apr 16, 2021 by Patrick Bafuma3 Biotech Stocks Ripe for Spring Portfolio CleaningAll down 45% or more from their 52-week highs, should you consider cutting your losses?
Apr 16, 2021 by Patrick BafumaThis Stock Just Popped 40%. Here's Why It Can Continue to Crush the MarketNovocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up.
Apr 9, 2021 by Patrick Bafuma3 Things Nano-X Needs to Do to Make You RichThe FDA recently cleared its digital X-ray concept; here's what has to happen next to generate shareholder value.
Apr 7, 2021 by Patrick BafumaBetter Healthcare Stock for the Next 10 Years: Butterfly Network vs. Shockwave MedicalWhich of these amazing medical technology companies is better for your portfolio for the next decade?
Apr 7, 2021 by Patrick BafumaDoes 2021's Best Biopharma to Work for Belong in Your Portfolio?Horizon Therapeutics has a clear path to significant sales growth.
Apr 4, 2021 by Patrick BafumaThis Medical Equipment Company's Recent Earnings Gave Investors ButterfliesButterfly Network's debut earnings call last week was impressive, but might have spooked some investors.
